<unk>  is used to treat diverse infections, including: * Prevention and treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease due to H. influenzae, M. catarrhalis, or S. pneumoniae. The benefits of long-term prophylaxis must be weighed on a patient-by-patient basis against the risk of cardiovascular and other adverse effects. * Community-acquired pneumonia due to C. pneumoniae, H. influenzae, M. pneumoniae, or S. pneumoniae * Uncomplicated skin infections due to S. aureus, S. pyogenes, or S. agalactiae * Urethritis and cervicitis due to C. trachomatis or N. gonorrhoeae. In combination with ceftriaxone,<unk>  is part of the United States Centers for Disease Control-recommended regimen for the treatment of gonorrhea.<unk>  is active as monotherapy in most cases, but the combination with ceftriaxone is recommended based on the relatively low barrier to resistance development in gonococci and due to frequent co-infection with C. trachomatis and N. gonorrhoeae. * Trachoma due to C. trachomatis * Genital ulcer disease (chancroid) in men due to H. ducrey *Acute bacterial sinusitis due to H. influenzae, M. catarrhalis, or S. pneumoniae. Other agents, such as amoxicillin/clavulanate are generally preferred, however. *Acute otitis media caused by H. influenzae, M. catarrhalis or S. pneumoniae.<unk>  is not, however, a first-line agent for this condition. Amoxicillin or another beta lactam antibiotic is generally preferred. *Pharyngitis or tonsillitis caused by S. pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy Sumamed 500 mg Bacterial susceptibility<unk>  has relatively broad but shallow antibacterial activity. It inhibits some Gram-positive bacteria, some Gram-negative bacteria, and many atypical bacteria. A strain of gonorrhea reported to be highly resistant to<unk>  was found in the population in 2015. Neisseria gonorrhoeae is normally susceptible to<unk> , but the drug is not widely used as monotherapy due to a low barrier to resistance development. Extensive use of<unk>  has resulted in growing Streptococcus pneumoniae resistance. Aerobic and facultative Gram-positive microorganisms * Staphylococcus aureus (Methicillin-sensitive only) * Streptococcus agalactiae * Streptococcus pneumoniae * Streptococcus pyogenes Aerobic and facultative anaerobic Gram-negative microorganisms * Haemophilus ducreyi * Haemophilus influenzae * Moraxella catarrhalis * Neisseria gonorrhoeae * Bordetella pertussis * Legionella pneumophila Anaerobic microorganisms * Peptostreptococcus species * Prevotella bivia Other microorganisms *Chlamydophila pneumoniae * Chlamydia trachomatis * Mycoplasma genitalium * Mycoplasma pneumoniae * Ureaplasma urealyticum Pregnancy and breastfeeding No harm has been found with use during pregnancy. However, there are no adequate well-controlled studies in pregnant women. The safety of the medication during breastfeeding is unclear. It was reported that because only low levels are found in breast milk and the medication has also been used in young children, it is unlikely that breastfed infants would suffer adverse effects. Nevertheless, it is recommended that the drug be used with caution during breastfeeding. Airway diseases<unk>  appears to be effective in the treatment of chronic obstructive pulmonary disease through its suppression of inflammatory processes. And potentially useful in asthma and sinusitis via this mechanism.<unk>  is believed to produce its effects through suppressing certain immune responses that may contribute to inflammation of the airways.
Azithromycin
Dirithromycin
Telithromycin
Roxithromycin
Levofloxacin
Moxifloxacin
Amoxicillin
Gemifloxacin